Abivertinib Maleate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Abivertinib Maleate, covering 2019-02-27 to 2019-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation [Phase 3]